Molecular pathology for classification of tumors and for efficacy prediction of targeted therapies is usually a swiftly growing discipline.Inside the INSEMA analyze – a prospectively randomized research evaluating SLNE vs. no SLNE in people with early invasive breast cancer (≤ 5 cm, cN0) and breast-conserving therapy – knowledge onThe sur